ReviewAntimicrobial resistance and infection control2026
Carbapenem-resistant Enterobacterales in Europe: strengthening AMR resilience through coordinated system-level action - lessons from Ukraine.
Review in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenem-resistant Enterobacterales (CRE) have emerged as one of the most serious antimicrobial resistance (AMR) threats in Europe. Rising incidence, substantial mortality, and marked heterogeneity across the EU/EEA pose a growing challenge. In Ukraine, an already substantial AMR burden and pre-existing limitations in diagnostic and infection prevention capacity, infectious diseases and antimicrobial stewardship (AMS) expertise, workforce resources, and access to effective antimicrobials have been further exacerbated by the war, including through damage to healthcare infrastructure and disruption of supply chains. These conditions facilitate the emergence and spread of CRE. As patient movement across Europe continues, CRE in Ukraine has become a shared European health security challenge. Although numerous national and international initiatives support AMR control in Ukraine, their impact is limited by fragmented implementation, insufficient coordination, and limited visibility across stakeholders. Drawing on hospital partnerships, multidisciplinary expert discussions, and emerging national coordination efforts in Ukraine, we argue that sustainable CRE control requires an integrated, system-level framework combining strengthened microbiological diagnostics and surveillance, infection prevention and control, infectious diseases and AMS expertise, and equitable access to effective antimicrobials. These components should be embedded within a coordinated national framework that aligns international support with national priorities. We describe the recently established, Ukrainian-led Public Health Center of the Ministry of Health of Ukraine (PHC) AMR Coordination Working Group as an emerging example, combining regular technical engagement, structured stakeholder collaboration, and plans to map international AMR-related activities in Ukraine. This approach may inform future European efforts to organise international AMR support in other high-burden and crisis-affected settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.